Castle Biosciences, Inc. (CSTL) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$25.76
Day's range
$27.03

Castle Biosciences Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 3.11 M $120.79 M   -2.65% 12.40%
VANGUARD GROUP INC 01/29/2026 2.20 M $85.57 M   1.27% 8.78%
RTW INVESTMENTS, LP 02/17/2026 2.12 M $82.28 M   100.00% 8.44%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 1.81 M $70.32 M   0.74% 7.22%
PORTOLAN CAPITAL MANAGEMENT, LLC 02/17/2026 1.73 M $67.28 M   14.15% 6.90%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 1.14 M $44.49 M   -22.41% 4.57%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 02/17/2026 1.06 M $41.18 M   164.68% 4.23%
STATE STREET CORP 02/13/2026 736.45 K $28.65 M   1.71% 2.94%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 714.91 K $27.81 M   2.33% 2.85%
AIGH CAPITAL MANAGEMENT LLC 02/02/2026 624.72 K $24.30 M   -11.67% 2.49%
ALLIANZ ASSET MANAGEMENT GMBH 02/11/2026 622.30 K $24.21 M   -4.02% 2.48%
PALISADE CAPITAL MANAGEMENT, LP 02/17/2026 567.78 K $22.09 M   -11.10% 2.27%
WASATCH ADVISORS LP 02/12/2026 537.24 K $20.90 M   -19.71% 2.14%
NUVEEN, LLC 02/12/2026 524.68 K $20.41 M   -45.18% 2.09%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 493.10 K $19.18 M   -12.35% 1.97%
SCHRODER INVESTMENT MANAGEMENT GROUP 02/13/2026 492.16 K $19.35 M   -0.56% 1.96%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 390.41 K $15.18 M   -13.56% 1.56%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 388.49 K $15.11 M   15.66% 1.55%
CITADEL ADVISORS LLC 02/17/2026 366.36 K $14.25 M   46.01% 1.46%
MILLENNIUM MANAGEMENT LLC 02/17/2026 308.91 K $12.02 M   -46.28% 1.23%
EVENTIDE ASSET MANAGEMENT, LLC 02/13/2026 305.00 K $11.86 M   100.00% 1.22%
GOLDMAN SACHS GROUP INC 03/25/2026 287.24 K $11.17 M   -16.77% 1.15%
KORNITZER CAPITAL MANAGEMENT INC /KS 02/02/2026 267.73 K $10.41 M   -3.80% 1.07%
BANK OF AMERICA CORP /DE/ 02/17/2026 263.02 K $10.23 M   -16.60% 1.05%
NORTHERN TRUST CORP 02/17/2026 262.24 K $10.20 M   -7.09% 1.05%
ADVISORS CAPITAL MANAGEMENT, LLC 01/29/2026 250.68 K $9.75 M   -1.39% 1.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/17/2026 246.92 K $9.61 M   39.36% 0.99%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 242.54 K $9.43 M   1.84% 0.97%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 235.52 K $9.16 M   6.59% 0.94%
NEW YORK STATE COMMON RETIREMENT FUND 02/12/2026 233.05 K $9.07 M   1.30% 0.93%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 218.56 K $8.50 M   100.00% 0.87%
SILVERCREST ASSET MANAGEMENT GROUP LLC 02/17/2026 205.00 K $7.97 M   -44.28% 0.82%
MORGAN STANLEY 02/13/2026 203.58 K $7.92 M   -24.50% 0.81%
BRAIDWELL LP 02/17/2026 177.18 K $6.89 M   -78.46% 0.71%
JANE STREET GROUP, LLC 02/12/2026 168.65 K $6.56 M   636.96% 0.67%
TUDOR INVESTMENT CORP ET AL 02/17/2026 167.18 K $6.50 M   95.68% 0.67%
D. E. SHAW & CO., INC. 02/17/2026 159.71 K $6.21 M   72.45% 0.64%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 01/15/2026 159.17 K $6.13 M   1.70% 0.64%
PARKMAN HEALTHCARE PARTNERS LLC 02/17/2026 150.56 K $5.86 M   -68.34% 0.60%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 150.01 K $5.84 M   7.22% 0.60%
UBS GROUP AG 01/29/2026 141.87 K $5.52 M   -51.31% 0.57%
INVESCO LTD. 02/19/2026 135.46 K $5.27 M   142.59% 0.54%
EMPOWERED FUNDS, LLC 02/18/2026 121.92 K $4.74 M   24.18% 0.49%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 119.46 K $4.65 M   -64.55% 0.48%
JPMORGAN CHASE & CO 02/11/2026 90.03 K $3.50 M   224.11% 0.36%
BANK OF NEW YORK MELLON CORP 02/10/2026 86.98 K $3.38 M   -7.48% 0.35%
TWO SIGMA INVESTMENTS, LP 02/17/2026 84.07 K $3.27 M   227.11% 0.34%
FRANKLIN RESOURCES INC 02/11/2026 80.60 K $3.14 M   -19.22% 0.32%
BIRCHVIEW CAPITAL, LP 02/13/2026 80.60 K $3.14 M   -27.12% 0.32%
AMERICAN CENTURY COMPANIES INC 02/13/2026 77.77 K $3.03 M   -5.75% 0.31%

Castle Biosciences Inc institutional Ownership - FAQ's

During the previous two years, 262 institutional investors and hedge funds held shares of Castle Biosciences Inc. The most heavily invested institutionals were:

PRINCIPAL FINANCIAL GROUP INC: 1.77 M

DIMENSIONAL FUND ADVISORS LP: 1.04 M

Allianz Asset Management GmbH: 811,324

AIGH Capital Management LLC: 590,601

Nuveen, LLC: 522,127

WASATCH ADVISORS LP: 455,036

109.02% of Castle Biosciences Inc stock is owned by institutional investors.

Institutional investors have bought a total of 32.46 M shares in the last 24 months. This purchase volume represents approximately $877.13 M in transactions.